An extracorporeal blood circulation device designed to provide cardiac and pulmonary support

Designed to oxygenate and circulate blood for up to 6 hours during cardiac surgery

The INSPIRA™ ART100 is expected to be the first system designed for integration with the company’s non-invasive HYLA™ blood sensor technology, a device that performs continuous blood measurements in real time, potentially minimizing the need to collect blood samples from patients and assisting physicians in monitoring an individual’s clinical condition.

The INSPIRA™ ART100 includes several Inspira Technologies developed features and capabilities, including a large touchscreen and novel colorful graphical representation that increases the visibility, scope and functionality of data displayed to the medical staff.
With its small footprint and lightweight characteristics, the INSPIRA™ ART100 device is being designed with a rapid style aerospace-grade aluminum structure to be both lightweight and highly durable, and will be equipped with long battery life, a contributing factor to making the device suitable for patient mobility within hospital.

The INSPIRA™ ART100 is expected to be submitted to the FDA for approval during the second half of 2023.

Get in Touch!

    Ha-Tidhar St 2, Ra'anana, Israel

    I consent to receive emails from Inspira Technologies Oxy B.H.N LTD. To request removal from the mailing list at any time, please send an email to You can find out about your rights and privacy choices, and how we use your information in our Privacy Policy.